The pharmaceutical science pertaining to the "collection, identification, assessment, monitoring, and prevention" of adverse effects with pharmaceutical goods is known as Pharmacovigilance (PV, or PhV), also known as Drug Safety. The words "pharmacovigilance" and "pharmakon," both from the Greek for "drug," have similar etymological roots (Latin for to keep watch). As a result, pharmacovigilance places a lot of emphasis on Adverse Drug Reactions (ADR), which are described as any noxious and unintended response to a drug, such as a lack of efficacy (the condition that this definition only applies with the doses normally used for the prophylaxis, diagnosis or therapy of disease, or for the modification of physiological disorder function was excluded with the latest amendment of the applicable legislation). Even in the absence of an adverse event, medication mistakes such as overdosing, drug addiction, misuse, and exposure to drugs while pregnant or nursing are of importance since, they may result in a negative pharmacological reaction. The data required for pharmacovigilance are provided through information obtained from patients and healthcare professionals via pharmacovigilance agreements, as well as from other sources including the medical literature. Most nations require the licence holder (often a pharmaceutical corporation) to provide adverse event data to the local drug regulatory body in order to market or test a pharmaceutical product.
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Exploring classical ayurvedic drugs in hypertension
Prashant Bhokardankar, Datta Meghe Ayurved College, India
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : A unique role and and impact of catalytic antibodies (abzymes) in clinical practice: A novel strategy for predicting and preventing relapse in chronic autoimmune conditions
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promising future of the unique translational tool to manage beta-cell population renewal and regeneration to secure the post-diabetic period
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Easily injectable, organic solvent free self assembled hydrogel platform for endoscope mediated gastrointestinal polypectomy
Hitasha Vithalani , IIT Gandhinagar, India